Compare LILA & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LILA | BLFS |
|---|---|---|
| Founded | 2017 | 1987 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2017 | 2013 |
| Metric | LILA | BLFS |
|---|---|---|
| Price | $8.88 | $36.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $13.00 | ★ $32.00 |
| AVG Volume (30 Days) | 345.7K | ★ 826.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.55 | ★ 77.27 |
| EPS | N/A | ★ 0.94 |
| Revenue | ★ $4,442,200,000.00 | $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | $7.23 | $17.82 |
| P/E Ratio | ★ N/A | $37.18 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $4.77 | $17.86 |
| 52 Week High | $9.04 | $38.10 |
| Indicator | LILA | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 54.66 |
| Support Level | $7.15 | $23.66 |
| Resistance Level | $9.04 | $38.10 |
| Average True Range (ATR) | 0.19 | 0.90 |
| MACD | -0.00 | -0.39 |
| Stochastic Oscillator | 98.20 | 31.00 |
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.